Montserrat vs North Macedonia: Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology
Montserrat
0.2%
in 2024
North Macedonia
0.2%
in 2024
Montserrat rank
98th
North Macedonia rank
98th
Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology over time
- Montserrat
- North Macedonia
How they compare
Montserrat currently reports 0.2% against 0.2% in North Macedonia, a difference of 0.0%.
The two have swapped places 1 time across 10 shared years of data; in 2015 it was Montserrat ahead.
Montserrat ranks 98th and North Macedonia ranks 98th of 246 countries.
Montserrat has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Montserrat | North Macedonia | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 0.3% | 0.1% | 0.2% | Montserrat |
| 2020s | 0.2% | 0.1% | 0.1% | Montserrat |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence of hepatitis b surface antigen (hbsag), 2026 methodology, Montserrat or North Macedonia?
- Montserrat, at 0.2% against 0.2% in North Macedonia as of 2024.
- What is the difference in prevalence of hepatitis b surface antigen (hbsag), 2026 methodology between Montserrat and North Macedonia?
- 0.0%, with Montserrat ahead.
- How many years of comparable data are there for Montserrat and North Macedonia?
- 10 years are reported by both, from 2015 to 2024.
- How do Montserrat and North Macedonia rank globally for prevalence of hepatitis b surface antigen (hbsag), 2026 methodology?
- Montserrat ranks 98th and North Macedonia ranks 98th of 246 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.